Telmisartan and Hyperkalemia - a phase IV clinical study of FDA data
Summary:
Hyperkalemia is reported as a side effect among people who take Telmisartan (telmisartan), especially for people who are female, 60+ old, have been taking the drug for 1 - 6 months also take Aspirin, and have Type 2 diabetes.
The phase IV clinical study analyzes which people have Hyperkalemia when taking Telmisartan. It is created by eHealthMe based on reports of 8,644 people who have side effects when taking Telmisartan from the FDA, and is updated regularly.
What is Telmisartan?
Telmisartan has active ingredients of telmisartan. It is often used in high blood pressure. eHealthMe is studying from 9,163 Telmisartan users. Check the latest studies of Telmisartan.
What is Hyperkalemia?
Hyperkalemia (damage to or disease of the kidney) is found to be associated with 1,957 drugs and 2,936 conditions by eHealthMe. Check the latest studies of Hyperkalemia.
8,644 people reported to have side effects when taking Telmisartan.
Among them, 74 people (0.86%) have Hyperkalemia.

Among these 74 people:
How long have people been on Telmisartan when they have Hyperkalemia? *
- < 1 month: 0.0 %
- 1 - 6 months: 66.67 %
- 6 - 12 months: 0.0 %
- 1 - 2 years: 16.67 %
- 2 - 5 years: 16.67 %
- 5 - 10 years: 0.0 %
- 10+ years: 0.0 %
What is the gender of people who have Hyperkalemia when taking Telmisartan? *
- female: 63.64 %
- male: 36.36 %
What is the age of people who have Hyperkalemia when taking Telmisartan? *
- 0-1: 0.0 %
- 2-9: 0.0 %
- 10-19: 0.0 %
- 20-29: 0.0 %
- 30-39: 0.0 %
- 40-49: 1.54 %
- 50-59: 23.08 %
- 60+: 75.38 %
What are other drugs people take besides Telmisartan? *
- Aspirin: 15 people, 20.27%
- Bisoprolol Fumarate: 13 people, 17.57%
- Furosemide: 12 people, 16.22%
- Gabapentin: 11 people, 14.86%
- Hydrochlorothiazide: 10 people, 13.51%
- Metformin Hydrochloride: 10 people, 13.51%
- Lovenox: 7 people, 9.46%
- Melatonin: 7 people, 9.46%
- Lithium Carbonate: 7 people, 9.46%
- Sitagliptin: 7 people, 9.46%
What are other side effects people have besides Hyperkalemia? *
- Acute Kidney Failure: 23 people, 31.08%
- Hypotension (abnormally low blood pressure): 15 people, 20.27%
- Diarrhea: 11 people, 14.86%
- Renal Impairment (severely reduced kidney function): 8 people, 10.81%
- Anaemia (lack of blood): 8 people, 10.81%
- Nausea (feeling of having an urge to vomit): 8 people, 10.81%
- Nausea And Vomiting: 8 people, 10.81%
- Lactic Acidosis (low ph in body tissues): 7 people, 9.46%
- Dehydration (dryness resulting from the removal of water): 5 people, 6.76%
- Pleural Effusion (water on the lungs): 5 people, 6.76%
What are the existing conditions these people have? *
- Pain: 10 people, 13.51%
- Type 2 Diabetes: 10 people, 13.51%
- Depression: 8 people, 10.81%
- Schizoaffective Disorder (a mental disorder characterized by disordered thought): 6 people, 8.11%
- Cardiac Failure: 4 people, 5.41%
- Heart Disease: 4 people, 5.41%
- Atrial Fibrillation/flutter (atrial fibrillation and flutter are abnormal heart rhythms in which the atria, or upper chambers of the heart, are out of sync with the ventricles): 3 people, 4.05%
- Diabetes: 3 people, 4.05%
- Hypothyroidism (abnormally low activity of the thyroid gland, resulting in retardation of growth and mental development): 2 people, 2.70%
- Breast Cancer Metastatic: 2 people, 2.70%
* Approximation only. Some reports may have incomplete information.
Do you take Telmisartan and have Hyperkalemia?
- Check whether Hyperkalemia is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously
Related studies:
Effectiveness of, long term effects of, and alternative drugs to Telmisartan:
- Telmisartan (9,163 reports)
Hyperkalemia treatments and more:
- Hyperkalemia (78,084 reports)
How severe was Hyperkalemia and when was it recovered:
Expand to all the drugs that have ingredients of telmisartan:
- Hyperkalemia and drugs with ingredients of telmisartan (634 reports)
Sub-studies by gender and age:
Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Browse all side effects of Telmisartan:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all the drugs that are associated with Hyperkalemia:
- Hyperkalemia (1,957 drugs)
Browse all the conditions that are associated with Hyperkalemia:
- Hyperkalemia (2,936 conditions)
Related publications that referenced our studies
- Kato Y, Mukai Y, Rane A, Inotsume N, Toda T, "The inhibitory effect of telmisartan on the metabolism of arachidonic acid by CYP2C9 and CYP2C8: an in vitro study", Biological and Pharmaceutical Bulletin, 2017 Sep .
- Kim HK, Youm JB, Lee SR, Lim SE, Lee SY, Ko TH, Nilius B, Noh JH, Ko KS, Rhee BD, Kim N, "The angiotensin receptor blocker and PPAR-γ agonist, telmisartan, delays inactivation of voltage-gated sodium channel in rat heart: novel mechanism of drug action", Pflügers Archiv-European Journal of Physiology, 2012 Dec .
- Kato Y, Mukai Y, Rane A, Inotsume N, Toda T, "The inhibitory effect of telmisartan on the metabolism of arachidonic acid by CYP2C9 and CYP2C8: an in vitro study", Biological and Pharmaceutical Bulletin, 2017 Sep .
- Kim HK, Youm JB, Lee SR, Lim SE, Lee SY, Ko TH, Nilius B, Noh JH, Ko KS, Rhee BD, Kim N, "The angiotensin receptor blocker and PPAR-γ agonist, telmisartan, delays inactivation of voltage-gated sodium channel in rat heart: novel mechanism of drug action", Pflügers Archiv-European Journal of Physiology, 2012 Dec .
How the study uses the data?
The study uses data from the FDA. It is based on telmisartan (the active ingredients of Telmisartan) and Telmisartan (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.
How to use the study?
DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.
Who is eHealthMe?
With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Could Embolex cause High Blood Pressure? - 14 seconds ago
- Drug interactions of Cetirizine Hydrochloride and Alvesco - 25 seconds ago
- Could Amaryl cause Oral Disorder? - 38 seconds ago
- Could Cytoxan cause Splenomegaly? - 45 seconds ago
- Could Aerobid cause Thrombotic Thrombocytopenic Purpura? - 59 seconds ago
- Bladder Spasm and Appetite Decreased - a minute ago
- Bladder Spasm and Appetite - Decreased - a minute ago
- Could Imdur cause Adverse Event? - a minute ago
- Could Hizentra cause Furuncle? - a minute ago
- Could Effexor Xr cause Cardiac Disorder? - a minute ago